Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosrenol in Stage 3 and 4 Chronic Kidney Disease
NCT00234702Phase 2Completed
- Sponsor
- Takeda
- Start
- Jan 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hyperphosphatemia comparing Lanthanum carbonate with Placebo (2 arms). Primary endpoint: Serum phosphorus levels at 8 weeks. Started Jan 2006; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00234702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234702.